Anticorps Polyclonal de lapin anti-Phospho-DLK/MAP3K12 (Thr43)

Phospho-DLK/MAP3K12 (Thr43) Polyclonal Antibody for WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, ELISA

Conjugaison

Non conjugué

Publications(1)

N° de cat : 28277-1-AP

Synonymes

DLK, Leucine zipper protein kinase, MAP3K12, MAPK upstream kinase, Mixed lineage kinase, MUK, Phospho-DLK/MAP3K12 (Thr43), ZPK, ZPKP1

---

Galerie de données de validation

• 

  WB analysis using 28277-1-AP

  Non-treated PC-3 and PDGF (HZ-1215) treated PC-3 cells were subjected to SDS PAGE followed by western blot with 28277-1-AP (Phospho-DLK (Thr43) antibody) at dilution of 1:600 incubated at 4℃ overnight.

---

Applications testées

• Résultats positifs en WB: cellules PC-3 traitées au PDGF,

Dilution recommandée

• Western Blot (WB): WB : 1:500-1:1000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 1 publications below
• WB: See 1 publications below

Informations sur le produit

28277-1-AP cible Phospho-DLK/MAP3K12 (Thr43) dans les applications de WB, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: Peptide
• Nom complet: mitogen-activated protein kinase kinase kinase 12
• Masse moléculaire calculée: 93 kda
• Poids moléculaire observé: 93 kDa
• Numéro d’acquisition GenBank: NM_001193511
• Symbole du gène: MAP3K12
• Identification du gène (NCBI): 7786
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

MAP3K12, also named as DLK ((dual leucine zipper kinase), is a part of a non-canonical MAPK signaling pathway. It has been reported that MAP3K12 can be activated by APOE through a receptor-mediated mechanism. MAP3K12 enhances the AP-1-mediated transcription of APP via a MAP kinase signal transduction pathway composed of MAP2K7, MAPK1/ERK2 and MAPK3/ERK1. MAP3K12 is required for pancreatic beta-cell proliferation during postnatal development and stress-induced JNK signaling in neurons.(PMID: 28111074, 25341110, 32189007)

Publications

Species	Application	Title
human	WB	Eur J Pharmacol; Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization; Authors - Xinyi Zheng ; KD Validated

{{ptg:RelatedPrimaryAntibodies}}